Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Repligen
Repligen
Activities:
Distribution
Manufacturing
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Regulatory
Purolite and Repligen launch a novel CH1 affinity resin for the purification of specialised mAbs
They launch Praesto CH1 a novel 70μm agarose-based affinite resin designed to purified specialised mAbs such as bispecifics or recombinant antibody fragments
Manufacturing
Sartorius and Repligen combine technologies for integrated bioreactor system
The two companies have incorporated Repligen XCell ATF upstream intensification technology into Sartorius’ Biostat STR bioreactor to simplify upstream process intensification
Manufacturing
Repligen partners with Daylight on mid-infrared tech
Through this agreement, Repligen will assume responsibility for the commercialisation of DRS Daylight’s Culpeo product
Manufacturing
Repligen plans Polymem acquisition to expand hollow fibre capabilities
The CDMO has made the acquisition to significantly expands hollow fibre membrane and module production capabilities for both industrial and bioprocessing markets
Manufacturing
Sartorius and Repligen collaborate on perfusion-enabled bioreactors
Joint technology to control cell growth, fluid management and cell retention would simplify development and cGMP manufacture of biological drugs
Manufacturing
Repligen completes expansion of US manufacturing facility in Massachusetts
More than doubles capacity for OPUS pre-packed chromatography columns
Manufacturing
Repligen to buy Novozymes Biopharma Sweden
Creates leading supplier of products for manufacturing biologic drugs
Subscribe now